ScholarLens Back to search
1999•Journal of Cardiac FailureRequires access

Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

Jay N. Cohn, Gianni Tognoni, Robert Glazer, Dirk Spormann, Allen Hester

Open publisher page 146 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 146 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Valsartan, Medicine, Heart failure, Angiotensin receptor, Cardiology, Internal medicine, Angiotensin II, Placebo

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure — Research Paper | ScholarLens